Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/2324709620974200 http://scihub22266oqcxt.onion/10.1177/2324709620974200 33238745!7705768!33238745     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Investig+Med+High+Impact+Case+Rep 2020 ; 8 (ä): 2324709620974200 Nephropedia Template TP {{tp|p=33238745|t=2020. A 23-Year-Old Man With Multisystem Inflammatory Syndrome After Mild COVID-19 |pdf=|usr=}}{{33238745}} gab.com Text A 23-Year-Old Man With Multisystem Inflammatory Syndrome After Mild COVID-19 JO: J Investig Med High Impact Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=33238745 #FOAvip We present the case of a young obese patient with recent COVID-19 (coronavirus disease 2019) who developed multisystem inflammatory syndrome (MIS) 1 month after spontaneous resolution. A 23-year-old African American man was admitted with a 1-week history of worsening fatigue, myalgias, headache, and dyspnea. Nasopharyngeal swab for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was negative by polymerase chain reaction; however, the patient was febrile and had leukocytosis, elevated troponin I, transaminitis, and acute kidney injury. Bedside echocardiogram showed decreased left ventricular ejection fraction (40% to 45%) and global hypokinesis in the setting of a type II non-ST segment myocardial infarction. Despite being on broad spectrum antibiotic therapy, the patient's clinical condition continued to worsen. The patient was then empirically treated for MIS with intravenous immunoglobulin and methylprednisolone, which led to a rapid resolution of fever and laboratory abnormalities. This case highlights that MIS associated with COVID-19 may present in patients above the age of 21 years and can occur with a delayed onset after mild illness in those with no previous oxygen requirement or hospitalization during SARS-CoV-2 infection. Twit Text FOAVip A 23-Year-Old Man With Multisystem Inflammatory Syndrome After Mild COVID-19 ????J Investig Med High Impact Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=33238745 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33238745 #FOAvip English Wikipedia <ref>{{Cite pmid|33238745}}</ref> A 23-Year-Old Man With Multisystem Inflammatory Syndrome After Mild COVID-19 #MMPMID33238745 Razavi AC; Chang JL; Sutherland A; Niyogi A; Menard GE J Investig Med High Impact Case Rep 2020[Jan]; 8 (ä): 2324709620974200 PMID33238745show ga We present the case of a young obese patient with recent COVID-19 (coronavirus disease 2019) who developed multisystem inflammatory syndrome (MIS) 1 month after spontaneous resolution. A 23-year-old African American man was admitted with a 1-week history of worsening fatigue, myalgias, headache, and dyspnea. Nasopharyngeal swab for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was negative by polymerase chain reaction; however, the patient was febrile and had leukocytosis, elevated troponin I, transaminitis, and acute kidney injury. Bedside echocardiogram showed decreased left ventricular ejection fraction (40% to 45%) and global hypokinesis in the setting of a type II non-ST segment myocardial infarction. Despite being on broad spectrum antibiotic therapy, the patient's clinical condition continued to worsen. The patient was then empirically treated for MIS with intravenous immunoglobulin and methylprednisolone, which led to a rapid resolution of fever and laboratory abnormalities. This case highlights that MIS associated with COVID-19 may present in patients above the age of 21 years and can occur with a delayed onset after mild illness in those with no previous oxygen requirement or hospitalization during SARS-CoV-2 infection. |*COVID-19 Drug Treatment[MESH] |COVID-19/*complications/*therapy[MESH] |Humans[MESH] |Male[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH] |Systemic Inflammatory Response Syndrome/*etiology/therapy[MESH]A 23-Year-Old Man With Multisystem Inflammatory Syndrome After Mild CO(epmc).pdf DeepDyve Pubget Overpricing